Cargando…

Berberine: Best Alternative Medicine Insight Abating Global Challenges for Treatment of MRSA Infections – Response to Comments of Savita V Jadhav [Response to Letter]

Detalles Bibliográficos
Autores principales:	Xia, Shuai, Ma, Liyan, Wang, Guoxing, Yang, Jie, Zhang, Meiying, Wang, Xuechen, Su, Jianrong, Xie, Miaorong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Response to Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233538/ https://www.ncbi.nlm.nih.gov/pubmed/35761977 http://dx.doi.org/10.2147/IDR.S376794

Ejemplares similares

Berberine: Best Alternative Medicine Insight Abating Global Challenges for Treatment of MRSA Infections [Letter]
por: Jadhav, Savita, et al.
Publicado: (2022)

In vitro Antimicrobial Activity and the Mechanism of Berberine Against Methicillin-Resistant Staphylococcus aureus Isolated from Bloodstream Infection Patients
por: Xia, Shuai, et al.
Publicado: (2022)

Response to Letter
por: Dalglish, Sarah L., et al.
Publicado: (2020)

In Response to the Letter by Nevin
por: Schneiderman, Aaron I., et al.
Publicado: (2019)

Response on Article “A Sustained-Release Nanosystem with MRSA Biofilm-Dispersing and -Eradicating Abilities Accelerates Diabetic Ulcer Healing” [Response to Letter]
por: Li, Zhiqing
Publicado: (2023)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Response to Letter]
por: Fifer, Simon, et al.
Publicado: (2023)

Letter to the editor response
por: Krawiec, Conrad, et al.
Publicado: (2022)

In Response to the Letter by Dramé et al.
por: Dorléans, Frédérique
Publicado: (2018)

Response to the letter by Esteves et al.
por: Send, T. S., et al.
Publicado: (2018)

Further Comments on the Effect of Precautionary Measures in Containing the Spread of Covid-19 [Response to Letter]
por: Alumran, Arwa
Publicado: (2020)

Best Practices in Peer Assessment: Training Tomorrow’s Physicians to Obtain and Provide Quality Feedback [Response to Letter]
por: Lerchenfeldt, Sarah, et al.
Publicado: (2020)

Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
por: Barsouk, Adam, et al.
Publicado: (2021)

Letter in Reply [Response To Letter]
por: Williams, Michelle K, et al.
Publicado: (2021)

Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Response to the letter
por: Nash, Sarah H., et al.
Publicado: (2020)

Response to the Letter
por: Yoon, Hyun, et al.
Publicado: (2021)

Response to the Letter
por: Arai, Hidekazu
Publicado: (2023)

Letter to the Editor Response Regarding “Research Equity in Otolaryngology–Head and Neck Surgery”
por: Patterson, Rolvix Harlan, et al.
Publicado: (2021)

Response to Letter from Dr. Volbeda and Colleagues Regarding COVID-19 and CKD
por: Sörling, Annika, et al.
Publicado: (2023)

Letter to the Editor: Response
por: Aune, Kyle T., et al.
Publicado: (2018)

“Anterior Chamber Depth After Phacovitrectomy” – Response to Letter to the Editor [Response to Letter]
por: Katz, Gabriel, et al.
Publicado: (2021)

Response to a Comment on “Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis”
por: Zhao, Peng, et al.
Publicado: (2023)

Letter to the Editor, International Journal of COPD [Response to Letter]
por: Llordés, Montserrat, et al.
Publicado: (2020)

Drive-by Photoscreening [Response to Letter]
por: Arnold, Robert, et al.
Publicado: (2021)

Letter to the Editor: Authors' Response
por: Cetin, Mehtap Bilgin, et al.
Publicado: (2022)

ANCA Associated Vasculitis Subtypes: Response [Response to Letter]
por: Austin, Keziah, et al.
Publicado: (2022)

Response to Letter “Regarding Development of a Surgical Video Atlas for Resident Education: 3-Year Experience”
por: Brown, Clifford Scott, et al.
Publicado: (2020)

Comments on: Internal Limiting Membrane Peeling and Gas Tamponade for Full-Thickness Macular Holes of Different Etiology – Is It Still Relevant? [Response to Letter]
por: Ruban, Andrii, et al.
Publicado: (2023)

Response to Letter by Dr. Cristina Brandolini
por: Kim, Hyun-Ah, et al.
Publicado: (2017)

Response to Letter by Dr. Ajay Malhotra
por: Yu, Xinyu, et al.
Publicado: (2020)

Using Tools as Designed [Response to Letter]
por: Zhou, Jiawei, et al.
Publicado: (2022)

Response to: "Letter to the Editor– Observation on the article titled “Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India”"
por: John, Christy V., et al.
Publicado: (2023)

Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
por: Brown, Jennifer R.
Publicado: (2021)

Response to the Letter: “A Response to: Human Fall Detection Using Passive Infrared Sensors with Low Resolution: A Systematic Review” [Response To Letter]
por: Ben-Sadoun, Grégory, et al.
Publicado: (2022)

Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Response to Letter]
por: Kaas-Hansen, Benjamin Skov, et al.
Publicado: (2022)

In-Situ Simulation: Effective and Efficient? [Response to Letter]
por: Shrestha, Roshana, et al.
Publicado: (2020)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
por: Lopez-Jaramillo, Patricio, et al.
Publicado: (2023)

Response to the letter to the editor “Nasal high-flow versus non-invasive ventilation in patients with chronic hypercapnic COPD” [Response to letter]
por: Wirtz, Hubert, et al.
Publicado: (2019)

Response to “Comment on ‘COVID-19, the Built Environment, and Health’”
por: Frumkin, Howard
Publicado: (2021)

Response to: Comment on The AI and I: A Collaboration on Competence
por: Funk, Luke M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ikhsr7rkk6jlirbv0a85h8ia5